Ripasudil

Ripasudil is a topical ophthalmic medication used to treat glaucoma, a group of eye conditions that can lead to optic nerve damage and vision loss. It is specifically designed to reduce intraocular pressure (IOP) in the eye, which is a critical factor in managing glaucoma.
Ripasudil works by inhibiting the production of a protein called Rho kinase, which plays a significant role in regulating the drainage of fluid from the eye. By suppressing Rho kinase activity, Ripasudil helps to increase the outflow of fluid from the eye, thereby reducing the IOP and alleviating the symptoms associated with glaucoma.
The medication is available in the form of eye drops and is typically administered once daily. Follow the prescribed dosage and instructions carefully to ensure the most effective treatment outcome. Ripasudil may cause some side effects, such as eye irritation, redness, or discomfort, but these are generally mild and temporary.
Ripasudil is not a cure for glaucoma, but rather a treatment to manage the condition and prevent further damage to the optic nerve. Regular eye examinations and adherence to the prescribed treatment plan are crucial for maintaining good vision and overall eye health.